MANGALAM GLOBAL ENTERPRISE
Back to Income Statement
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,281 Cr | ₹1,839 Cr | ₹1,424 Cr | ₹1,279 Cr | ₹960 Cr |
What is the latest Revenue of MANGALAM GLOBAL ENTERPRISE ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,281 Cr |
| Mar2024 | ₹1,839 Cr |
| Mar2023 | ₹1,424 Cr |
| Mar2022 | ₹1,279 Cr |
| Mar2021 | ₹960 Cr |
How is Revenue of MANGALAM GLOBAL ENTERPRISE Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,281 Cr | 24.09 | |
| Mar2024 | ₹1,839 Cr | 29.09 | |
| Mar2023 | ₹1,424 Cr | 11.36 | |
| Mar2022 | ₹1,279 Cr | 33.24 | |
| Mar2021 | ₹960 Cr | - | |
Compare Revenue of peers of MANGALAM GLOBAL ENTERPRISE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM GLOBAL ENTERPRISE | ₹449.2 Cr | -1.4% | 9.4% | 6.9% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,624.9 Cr | 0.9% | 1.8% | -14.3% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,730.6 Cr | -6.5% | -0.6% | -35.3% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,278.2 Cr | -3.9% | 7.9% | -3.7% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹995.9 Cr | -0.6% | -5.4% | -26.6% | Stock Analytics | |
| INDO US BIOTECH | ₹210.6 Cr | -4.6% | -1.9% | -31.5% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM GLOBAL ENTERPRISE | -1.4% |
9.4% |
6.9% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses